By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

GeneDx Holdings Corp. (WGS)

NASDAQ Currency in USD
$125.89
+$2.70
+2.19%
Last Update: 11 Sept 2025, 20:00
$3.62B
Market Cap
6.29K
P/E Ratio (TTM)
Forward Dividend Yield
$35.88 - $136.00
52 Week Range

WGS Stock Price Chart

Explore GeneDx Holdings Corp. interactive price chart. Choose custom timeframes to analyze WGS price movements and trends.

WGS Company Profile

Discover essential business fundamentals and corporate details for GeneDx Holdings Corp. (WGS) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Healthcare Information Services

IPO Date

4 Nov 2020

Employees

1.00K

CEO

Katherine A. Stueland

Description

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

WGS Financial Timeline

Browse a chronological timeline of GeneDx Holdings Corp. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 28 Apr 2026

Upcoming earnings on 16 Feb 2026

Upcoming earnings on 4 Nov 2025

EPS estimate is $0.33.

Earnings released on 29 Jul 2025

EPS came in at $0.50 surpassing the estimated $0.10 by +400.00%, while revenue for the quarter reached $102.69M , beating expectations by +4.11%.

Earnings released on 30 Apr 2025

EPS came in at $0.28 surpassing the estimated $0.11 by +154.55%, while revenue for the quarter reached $87.12M , beating expectations by +2.11%.

Earnings released on 18 Feb 2025

EPS came in at $0.70 surpassing the estimated $0.04 by +1.65K%, while revenue for the quarter reached $95.64M , beating expectations by +21.09%.

Earnings released on 29 Oct 2024

EPS came in at $0.04 surpassing the estimated -$0.19 by +121.05%, while revenue for the quarter reached $76.87M , missing expectations by -4.18%.

Earnings released on 30 Jul 2024

EPS came in at -$0.11 surpassing the estimated -$0.26 by +57.69%, while revenue for the quarter reached $70.51M , beating expectations by +18.89%.

Earnings released on 29 Apr 2024

EPS came in at -$0.33 surpassing the estimated -$0.68 by +51.47%, while revenue for the quarter reached $62.42M , beating expectations by +6.96%.

Earnings released on 20 Feb 2024

EPS came in at -$0.59 surpassing the estimated -$0.60 by +1.67%, while revenue for the quarter reached $57.42M , beating expectations by +3.59%.

Earnings released on 30 Oct 2023

EPS came in at -$0.82 surpassing the estimated -$1.18 by +30.51%, while revenue for the quarter reached $53.30M , beating expectations by +7.03%.

Earnings released on 8 Aug 2023

EPS came in at -$1.65 falling short of the estimated -$1.47 by -12.24%, while revenue for the quarter reached $48.71M , missing expectations by -9.77%.

Earnings released on 9 May 2023

EPS came in at -$2.82 falling short of the estimated -$1.65 by -70.91%, while revenue for the quarter reached $43.14M , missing expectations by -7.11%.

Stock split effective on 4 May 2023

Shares were split 1 : 33 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 14 Mar 2023

EPS came in at -$0.25 falling short of the estimated -$0.16 by -56.25%, while revenue for the quarter reached $61.35M , missing expectations by -13.53%.

Earnings released on 14 Nov 2022

EPS came in at -$0.20 surpassing the estimated -$0.21 by +4.76%, while revenue for the quarter reached $83.23M , beating expectations by +22.87%.

Earnings released on 15 Aug 2022

EPS came in at -$0.25 falling short of the estimated -$0.21 by -19.05%, while revenue for the quarter reached $36.17M , missing expectations by -46.46%.

Earnings released on 12 May 2022

EPS came in at -$0.31 matching the estimated -$0.31, while revenue for the quarter reached $53.94M , beating expectations by +13.56%.

Earnings released on 14 Mar 2022

EPS came in at -$0.17 surpassing the estimated -$0.26 by +34.62%, while revenue for the quarter reached $57.80M , beating expectations by +16.37%.

Earnings released on 15 Nov 2021

EPS came in at -$0.43 falling short of the estimated -$0.19 by -126.32%, while revenue for the quarter reached $43.18M .

Earnings released on 21 Jul 2021

EPS came in at -$25.86 , while revenue for the quarter reached $46.87M .

Earnings released on 24 May 2021

EPS came in at -$114.35 , while revenue for the quarter reached $64.20M .

Earnings released on 30 Mar 2021

EPS came in at -$74.94 , while revenue for the quarter reached $63.96M .

Earnings released on 30 Sept 2020

EPS came in at -$33.76 , while revenue for the quarter reached $38.61M .

WGS Stock Performance

Access detailed WGS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run